We hypothesize that inhibition of key miRNAs within the miR-17/92 cluster (miR-17, miR-19a, and miR-20a) using sponge constructs will destabilize the MYC dosage compensation system, unleash cytotoxicity and reduce tumor cell viability depending on MYC expression levels. The gene discussed is MYC; the disease is neoplasm.